Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct;199(4):396.e1-7.
doi: 10.1016/j.ajog.2008.06.088.

Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates

Affiliations
Free article

Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates

Neil S Seligman et al. Am J Obstet Gynecol. 2008 Oct.
Free article

Abstract

Objective: The objective of the study was to identify maternal variables predicting length of treatment for neonatal abstinence syndrome (NAS).

Study design: This was a retrospective cohort study of infants treated for NAS during 2000-2006 whose mothers were on methadone maintenance at delivery. Mixed-effects linear regression was used to examine the interaction of maternal and neonatal variables with length of treatment.

Results: Of 204 neonates born to methadone exposed mothers, the average dose at delivery was 127 mg daily (25-340 mg) with median length of treatment 32 days (1-122 days). Trimester of initial exposure (P = .33), methadone dose at delivery (P = .198), body mass index (P = .31), antidepressant use (P = .40), cigarette use (P = .76), race (P = .78), and maternal age (P = .84) did not predict length of treatment. In the multivariate analysis, gestational age at delivery and benzodiazepine use were significant predictors of length of treatment.

Conclusion: Later gestational age and concomitant benzodiazepine use were associated with longer treatment.

PubMed Disclaimer